Generation Investment Management LLP purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 6,761,596 shares of the conglomerate’s stock, valued at approximately $1,287,949,000. Danaher accounts for about 12.5% of Generation Investment Management LLP’s investment portfolio, making the stock its biggest holding. Generation Investment Management LLP owned approximately 0.96% of Danaher as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the period. Legal & General Group Plc increased its stake in shares of Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after purchasing an additional 43,169 shares during the period. Advisors Capital Management LLC increased its stake in shares of Danaher by 14.0% in the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after purchasing an additional 6,720 shares during the period. Handelsbanken Fonder AB lifted its position in shares of Danaher by 10.9% during the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock worth $55,091,000 after purchasing an additional 28,425 shares during the last quarter. Finally, Swiss Life Asset Management Ltd boosted its stake in Danaher by 12.1% during the 4th quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock valued at $26,402,000 after purchasing an additional 12,416 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Performance
Danaher stock opened at $211.92 on Thursday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market capitalization of $148.98 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78. The stock has a fifty day moving average price of $194.30 and a two-hundred day moving average price of $192.44. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Analysts Set New Price Targets
Several research analysts have commented on DHR shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target on the stock. Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Finally, Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $228.91.
Get Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
